Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...
U.S. court invalidates Teva’s Copaxone patent
The U.S. Court of Appeals has again ruled that Teva Pharmaceuticals Industries Ltd.’s patent for its top-selling multiple sclerosis treatment Copaxone is invalid. A Teva spokeswoman said that the company is More...
Three way takeover battle: Abbott Labs to back Mylan’s acquisition of Perrigo
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott Lab potentially helping Mylan forfend More...
Three Way Takeover Battle: Statistics weigh against Teva’s Mylan bid succeeding
Will drug company Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) succeed in its attempted hostile takeover of rival Mylan (MYL), or will it be Mylan that succeeds in its own hostile takeover More...
Teva Issues New Letter to Mylan NV Confirming Seriousness Of Offer To Acquire Mylan
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) issued a new open letter on Monday, signed by both the Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, addressed to More...
Mylan to Teva: stop playing games with our company
Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule More...
Mylan’s CEO on Teva “They are getting ready to go off the cliff”
“We just don’t think Teva is the right company” to combine with, “They are getting ready to go off the cliff, ” Mylan NV, CEO Heather Bresch said Friday at a conference in New York City hosted More...
Three Way Takeover Battle: Mylan mulling improved offer for Perrigo – Bloomberg
Mylan (MYL) is considering an improved offer to shareholders of Perrigo (PRGO) with the aim of acquiring the company and thus heading off the hostile bid for Mylan from Teva Pharmaceutical Industries Ltd. (NYSE: More...
Teva takeover supporter Paulson raises Mylan stake
John Paulson‘s hedge fund has increased its holdings in Mylan NV to 4.5%. The fund, which supports Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA; TASE: TEVA) takeover bid for Mylan, More...
Teva loses Copaxone patent appeal
– The decision maintains exclusivity for Copaxone until May 24, 2014. – Copaxone/ source : dynamik3d.ca – On Friday, the US Court of Appeals for the Federal Circuit ruled in favor of More...